)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Bioretec
Bioretec (BRETEC) investor relations material
Bioretec Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary13 Aug, 2026
Executive summary
Net sales for H1 2026 increased by 11.9% year-over-year to EUR 2.32 million, with Q2 net sales up 62.2% to EUR 1.1 million, driven by strong growth in the U.S. and Europe.
Adjusted sales margin improved to 69.2% in H1 2026 from 56.8% a year earlier, reflecting a favorable sales mix and higher-margin markets.
EBITDA loss narrowed to EUR -3.63 million in H1 2026 from EUR -4.56 million in H1 2025, with net loss at EUR -4.68 million, including EUR 1.01 million in rights issue costs.
Strategic focus remains on expanding the RemeOs™ platform, operational efficiency, and disciplined execution.
Financial highlights
Q2 2026 net sales rose 62.2% year-over-year, with 133.6% growth in the U.S. and 63.9% in Europe.
Adjusted sales margin reached 68.0% in Q2 and 69.2% in H1 2026.
EBITDA for H1 2026 was EUR -3.63 million, an improvement from EUR -4.56 million in H1 2025.
Net loss for H1 2026 was EUR -4.68 million, improved from EUR -5.63 million in H1 2025.
Cash and cash equivalents at period end were EUR 12.02 million, up 4.8% year-over-year.
Outlook and guidance
Sufficient working capital is expected to support execution of the current business plan into Q3 2027.
Strategic priorities for 2026-2028 include launching one new product every 12-18 months and establishing RemeOs™ as a leading absorbable product family.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bioretec
- Adjusted sales margin rose to 70.1% as U.S. and European sales saw triple-digit growth.BRETEC
Q1 2026 - Net sales dropped 22.5% in 2025, but U.S. direct sales surged 60% quarter-over-quarter.BRETECQ4 2025
- Sales rose slightly, but losses deepened as strategy and commercialization shift.BRETECQ3 2025
- H1 2025 saw flat sales, a widened net loss, and a successful EUR 9M capital raise.BRETECQ2 2025
- Q3 2024 net sales up 42% year-over-year; U.S. and EU product launches drive future growth.BRETECQ3 2024
- Net sales up 9% in H1 2024, driven by U.S. and Europe, with losses narrowing.BRETECQ2 2024
- Q1 2025 sales surged 105% as Bioretec accelerated global expansion and secured CE approval.BRETECQ1 2025
- CE mark for RemeOs Trauma Screw and EUR 6M funding set stage for Bioretec's growth.BRETECQ4 2024
Next Bioretec earnings date
Q3 202612 Nov, 2026
Bioretec
Next Bioretec earnings date
Q3 202612 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage